Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)
Sector: Medical
Current Price :
$38.04
52 Week Low
$24.02
52 Week High
$38.34
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
115M
Market Cap:
$4.24B
Avg Volume:
966216
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
This Could Be The BEST Way To Own Small-Cap Stocks
Mar 29, 2012 04:10 PM |
BMRN
,
CPO
,
ITC
,
OIS
,
PNRA
Brean Murray Upgrades Biomarin Pharma (BMRN) To 'Buy' On GALNS Late-Study Trial Timing
Mar 19, 2012 10:31 AM |
BMRN
3 Companies That Might Be Bought Soon...
Feb 21, 2012 02:10 PM |
BMRN
,
BMY
,
GILD
,
INCY
,
INHX
,
LLY
Ports In A Storm - Best Performing Stocks During This Down Movement
Oct 06, 2011 03:08 PM |
AAPL
,
ALXN
,
ARJ
,
AUY
,
AZO
,
BAB
Analysts Upgrades & Downgrades: BPO, BMRN, RL, MWV, IFT
Sep 28, 2011 10:27 AM |
BMRN
,
BPO
,
MWV
,
RL
More Articles on BMRN..
Market News
Report: Marin's economy will continue rebound
May 06, 2011 04:04 AM |
BMRN
More News on BMRN..
Press Releases
BioMarin Appoints Dan Spiegelman as Executive Vice President and Chief Financial Officer
May 08, 2012 04:00 PM |
BMRN
BioMarin to Present at the Deutsche Bank Healthcare Conference
May 08, 2012 09:01 AM |
BMRN
BioMarin to Present at the Baird Growth Stock Conference
May 08, 2012 09:01 AM |
BMRN
More Press Releases on BMRN..
SEC Filings
Form 4 BIOMARIN PHARMACEUTICAL For: May 22 Filed by: Mueller Brian (10K)
May 23, 2012 08:13 PM
Form 4 BIOMARIN PHARMACEUTICAL For: May 16 Filed by: BIENAIME JEAN JACQUES (10K)
May 18, 2012 06:32 PM
Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: LAWLIS V BRYAN (10K)
May 17, 2012 06:33 PM
More SEC Filings on BMRN..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
BMRN
Compare to S&P
YTD
6.60 %
-4.38 %
4 Weeks
11.03 %
12.05 %
12 Weeks
-3.63 %
-4.88 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
8.70 %
EPS Growth in Last Year:
-425.00 %
Sales Growth in Last Quarter:
8.16 %
Sales Growth in Last Quarter:
6.57 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##